Gilead Sciences



Ebit Veränderung Datum
AbbVie USD 5.65B 407M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 3.6B 434M 2025-03
Biogen USD 582.8M 61.3M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Eli Lilly USD 3.7B 1.93B 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 283.64M 92.62M 2025-03
J&J USD 7.39B 2.04B 2025-03
Merck USD 5.22B 339M 2024-12
Moderna USD -963000000 283M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
PTC Therapeutics USD 970.22M 1.13B 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Sanofi EUR 2.9B 824M 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Gilead Sciences - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.